ArticleFrontiers in endocrinology2022

FT4/FT3 ratio: A novel biomarker predicts coronary microvascular dysfunction (CMD) in euthyroid INOCA patients.

Han Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.